Effect of Omalizumab in the Skin of Food Allergy Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Omalizumab in the Skin of Food Allergy Patients — Stella

Home/Food Allergy/

View on ClinicalTrials.gov

Recruiting

Back to Food Allergy trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

National Jewish Health, Denver, Colorado

Key details

Phase

Post-approval study

Sponsor

National Jewish Health

Collaborators

Roche-Genentech

Enrollment target

~40 participants

Started

October 2024

Primary completion

September 2026

Age range

1 Year – 55 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.